Respicardia Garners $6,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=31dc627e-bedb-4d57-a060-5d97942ae091&Preview=1 -
Date
8/8/2012 -
Company Name
Respicardia -
Mailing Address
12400 Whitewater Dr Minnetonka, MN 55343 -
Company Description
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. -
Website
http://www.respicardia.com -
Transaction Type
Debt -
Transaction Amount
$6,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The money will be used for working capital and to complete a pilot study of the company’s sleep apnea treatment. -
M&A Terms
-
Venture Investor
Ares Capital
